anoth
reason
understand
evid
harm
benefit
corticosteroid
immedi
clinic
import
discuss
clinic
outcom
corticosteroid
use
coronaviru
similar
outbreak
tabl
acut
lung
injuri
acut
respiratori
distress
syndrom
partli
caus
host
immun
respons
corticosteroid
suppress
lung
inflamm
also
inhibit
immun
respons
pathogen
clearanc
sarscov
infect
influenza
system
inflamm
associ
advers
outcom
sar
inflamm
persist
viral
clearanc
pulmonari
histolog
sar
mer
infect
reveal
inflamm
diffus
alveolar
damag
one
report
suggest
haemophagocytosi
theoret
corticosteroid
treatment
could
role
suppress
lung
inflamm
retrospect
observ
studi
report
adult
critic
ill
mer
almost
half
patient
given
corticosteroid
median
hydrocortison
equival
dose
ie
methylprednisolon
dexamethason
prednisolon
mgday
patient
given
corticosteroid
like
requir
mechan
ventil
vasopressor
renal
replac
therapi
statist
adjust
immort
time
indic
bias
author
conclud
administr
corticosteroid
associ
differ
mortal
adjust
odd
ratio
ci
associ
delay
clearanc
viral
rna
respiratori
tract
secret
adjust
hazard
ratio
ci
howev
effect
estim
high
risk
error
due
probabl
presenc
unmeasur
confound
metaanalysi
corticosteroid
use
patient
sar
four
studi
provid
conclus
data
indic
harm
first
casecontrol
studi
sar
patient
without
sarsrel
psychosi
given
corticosteroid
treatment
develop
psychosi
given
higher
cumul
dose
mg
hydrocortison
equival
vs
mg
second
randomis
control
trial
patient
sar
critic
ill
nine
patient
given
hydrocortison
mean
day
ci
sinc
fever
onset
greater
viraemia
second
third
week
infect
given
salin
control
remain
two
studi
report
diabet
avascular
necrosi
complic
associ
corticosteroid
treatment
systemat
review
metaanalysi
identifi
ten
observ
studi
influenza
total
patient
investig
found
increas
mortal
patient
given
corticosteroid
risk
ratio
rr
ci
among
outcom
length
stay
intens
care
unit
increas
mean
differ
ci
p
rate
secondari
bacteri
fungal
infect
rr
ci
corticosteroid
investig
respiratori
syncyti
viru
rsv
clinic
trial
children
conclus
evid
benefit
therefor
recommend
observ
studi
adult
rsv
infect
given
among
patient
surviv
corticosteroid
treatment
avascular
necrosi
osteoporosi
influenza
increas
mortal
risk
ratio
mortal
ci
metaanalysi
patient
ten
studi
clinic
benefit
children
effect
largest
randomis
control
trial
children
treat
corticosteroid
covcoronaviru
mersmiddl
east
respiratori
syndrom
rsvrespiratori
syncyti
viru
sarssever
acut
respiratori
syndrom
hydrocortison
methylprednisolon
dexamethason
prednisolon
corticosteroid
suggest
impair
antibodi
respons
day
given
corticosteroid
lifethreaten
acut
respiratori
distress
syndrom
occur
infect
howev
generalis
evid
acut
respiratori
distress
syndrom
studi
viral
lung
injuri
problemat
trial
typic
includ
major
patient
acut
respiratori
distress
syndrom
nonpulmonari
steril
caus
review
treatment
acut
respiratori
distress
syndrom
caus
base
six
studi
total
patient
conclud
insuffici
evid
exist
recommend
corticosteroid
treatment
septic
shock
report
seven
patient
includ
publish
report
jan
corticosteroid
wide
use
septic
shock
despit
uncertainti
efficaci
patient
septic
shock
trial
bacteri
infect
lead
vasopleg
shock
myocardi
insuffici
group
potenti
net
benefit
might
deriv
steroid
treatment
sever
shock
howev
shock
sever
hypoxaem
respiratori
failur
often
consequ
increas
intrathorac
pressur
invas
ventil
imped
cardiac
fill
vasoplegia
context
steroid
treatment
unlik
provid
benefit
clinic
data
exist
indic
net
benefit
deriv
corticosteroid
treatment
respiratori
infect
due
rsv
influenza
sarscov
merscov
avail
observ
data
suggest
increas
mortal
secondari
infect
rate
influenza
impair
clearanc
sarscov
merscov
complic
corticosteroid
therapi
survivor
present
effect
steroid
mortal
septic
shock
small
unlik
generalis
shock
context
sever
respiratori
failur
due
overal
uniqu
reason
exist
expect
patient
infect
benefit
corticosteroid
might
like
harm
treatment
conclud
corticosteroid
treatment
use
treatment
lung
injuri
shock
outsid
clinic
trial
